Clients News • MC Services corporate website
paged,page-template-default,page,page-id-5522,paged-7,page-paged-7,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.5.0,vc_responsive




  • RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.
  • XPhyto builds commercial team to launch 25-minute COVID-19 RT-PCR test
  • CENTOGENE GmbH: CENTOGENE führt Studie zur Untersuchung des SARS-CoV-2-Infektionsrisikos im Öffentlichen Personen-Nahverkehr in Zusammenarbeit mit der Charité Research Organisation durch
  • Marinomed Biotech AG shares positive clinical trial results for iota-carrageenan nasal spray in the prevention of COVID-19
  • RedHill Biopharma Strengthens Partnership with Cosmo Pharmaceuticals with Manufacturing Agreements for Movantik and RHB-204
  • CENTOGENE GmbH: Science Meets Culture: CENTOGENE’s Rare Disease Day 2021 Activities
  • Marinomed Biotech AG publishes new supporting data on the in vitro efficacy of Carragelose® against SARS-CoV-2
  • RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107
  • Imcyse SA: Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round – Pfizer Joins as Newest Shareholder
  • DEBx Medical publishes first clinical data on novel desiccant gel for chemical debridement of infected, chronic wounds in peer-reviewed journal, Wounds